Kindred Biosciences to Participate in the B. Riley FBR Institutional Investor Conference, Stifel 2019 Dental & Veterinary Conference and 9th Annual LD Micro Invitational

May 13, 2019

SAN FRANCISCO , May 13, 2019 /PRNewswire/ --  Kindred Biosciences, Inc. (NASDAQ: ...

Kindred Biosciences Announces First Quarter 2019 Financial Results

May 9, 2019

SAN FRANCISCO , May 9, 2019 /PRNewswire/ --  Kindred Biosciences, Inc. (NASDAQ: K...

Kindred Biosciences to Announce First Quarter 2019 Financial Results

April 25, 2019

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m....

Kindred Biosciences Announces Fourth Quarter and Full Year 2018 Financial Results

March 6, 2019

SAN FRANCISCO , March 6, 2019 /PRNewswire/ --  Kindred Biosciences, Inc. (NASDAQ:...

Kindred Biosciences to Announce Fourth Quarter and Year-End 2018 Financial Results

February 19, 2019

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m....

Kindred Biosciences to Present at Bank of America Merrill Lynch Animal Health Summit and Barclays Global Healthcare Conference

February 13, 2019

SAN FRANCISCO , Feb. 13, 2019 /PRNewswire/ --  Kindred Biosciences, Inc.  (NASDAQ...

Kindred Biosciences Announces Closing of Public Offering of Common Stock and the Full Exercise of Underwriters' Option to Purchase Additional Shares

January 23, 2019

SAN FRANCISCO , Jan. 23, 2019 /PRNewswire/ --  Kindred Biosciences, Inc. (NASDAQ:...

Kindred Biosciences Named Best Company in North America by Leading Industry Publication

January 22, 2019

SAN FRANCISCO , Jan. 22, 2019 /PRNewswire/ --  Kindred Biosciences, Inc. (NASDAQ:...

Kindred Biosciences Announces Pricing of Public Offering

January 18, 2019

SAN FRANCISCO , Jan. 18, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...

Kindred Biosciences Announces Proposed Public Offering of Common Stock

January 17, 2019

SAN FRANCISCO , Jan. 17, 2019 /PRNewswire/ --  Kindred Biosciences, Inc. (NASDAQ:...

Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study of epoCat™ for the Management of Non-Regenerative Anemia in Cats and Availability of Mirataz® at Banfield Pet Hospital

January 14, 2019

SAN FRANCISCO , Jan. 14, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...